EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
08. April 2024 08:00 ET
|
Genetic Technologies Ltd
Humanise Health & GeneType and launch "Know Your Risk" event
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
02. April 2024 08:05 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 02, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
GTG Global Collaborations and Innovation Update
26. März 2024 08:00 ET
|
Genetic Technologies Ltd
GTG Global Collaborations and Innovation Update
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
25. März 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, March 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GENE”), a global leader in guideline-driven genomics-based testing in health, wellness...
GTG to launch U.S. Customer Digital Media Sales Campaign
28. Februar 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), is pleased to announce the launch of a wide-reaching customer – targeted...
Launching our most comprehensive test and expanding into new global markets
31. Januar 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE), is at the forefront in personalised predictive genomics, reshaping the healthcare landscape with...
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
05. Januar 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”) a global leader in genomics-based tests in health, wellness, and serious disease,...
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
14. Dezember 2023 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies (GTG) is proud to provide details of a series of recent transformative initiatives. Our commitment to advancing early...
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
12. Dezember 2023 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
30. Oktober 2023 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health,...